1034912-28-1 Usage
Uses
Used in Pharmaceutical Industry:
(1R,4S)-tert-butyl 2-azabicyclo[2.2.1]heptane-2-carboxylate is used as a pharmaceutical intermediate for the synthesis of various drugs. Its unique molecular structure and functional groups make it a valuable building block in the development of new medications, particularly in the fields of central nervous system (CNS) disorders and pain management.
Used in Chemical Research:
(1R,4S)-tert-butyl 2-azabicyclo[2.2.1]heptane-2-carboxylate serves as a key compound in chemical research, particularly in the study of stereochemistry and the development of asymmetric synthesis methods. Its complex structure and functional groups provide opportunities for exploring novel reaction pathways and catalysts, contributing to the advancement of organic chemistry.
Used in Material Science:
(1R,4S)-tert-butyl 2-azabicyclo[2.2.1]heptane-2-carboxylate is utilized as a component in the development of new materials, such as polymers and composites, with unique properties. Its incorporation into these materials can lead to enhanced mechanical strength, thermal stability, or other desirable characteristics, making it a valuable resource in material science applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1034912-28-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,4,9,1 and 2 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1034912-28:
(9*1)+(8*0)+(7*3)+(6*4)+(5*9)+(4*1)+(3*2)+(2*2)+(1*8)=121
121 % 10 = 1
So 1034912-28-1 is a valid CAS Registry Number.
1034912-28-1Relevant articles and documents
PIPERIDINUM COMPOUNDS FOR THE TREATMENT OF OBSTRUCTIVE PULMONARY DISEASES (COPD)
-
Page/Page column 51, (2008/12/06)
The invention provides compounds of formula (I), wherein R1, R2, R3, R4, R5, R6, g, h and X are as defined in the specification, a process for their preparation, pharmaceutical compositions containing them, a process for preparing pharmaceutical compositions, their use in therapy and intermediates of use in their preparation.
